State Street’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
Other funds holding NRXP
State Street's NRXP Position: Q3 2026 in Review
State Street increased its NRX Pharmaceuticals (NRXP) stake by 8% in Q3 2026, buying an estimated $33K and bringing the position to 125,384 shares worth $366K. The position accounts for ﹤0.01% of the portfolio, ranked #3742.
State Street first reported a position in NRXP in Q4 2021 and has held it in 20 quarters since. The position peaked at $475K in Q2 2026. 33 funds tracked by Wall St. Rank hold NRXP as of Q3 2026.
- State Street held 125,384 shares of NRX Pharmaceuticals worth $366K as of Q3 2026.
- State Street bought 9,300 NRX Pharmaceuticals shares in Q3 2026, an estimated $33K.
- NRX Pharmaceuticals made up ﹤0.01% of State Street's portfolio in Q3 2026, its #3742 holding.
- State Street first reported a position in NRX Pharmaceuticals in Q4 2021 and has held it in 20 quarters since.
- State Street's NRX Pharmaceuticals position peaked at $475K in Q2 2026.
- 33 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q3 2026.
Based on State Street's 13F filing for Q3 2026, filed 12 Nov 2026.